Retour sur lavenir.net
   NYXOAH 1.402 € (+0,29 %)     ARGENX SE 762.800 € (+0,24 %)     CMB.TECH 14.540 € (+0,97 %)     AB INBEV 68.740 € (+0,09 %)     UCB 220.300 € (-0,68 %)     D'IETEREN GROUP 175.700 € (-0,51 %)     AEDIFICA 68.050 € (-0,07 %)     WDP 21.280 € (-0,47 %)     SOLVAY 25.980 € (-2,48 %)     ASCENCIO 51.900 € (0,00 %)     BEKAERT 38.050 € (+0,53 %)     VAN DE VELDE 29.600 € (-0,34 %)     HOME INVEST BE. 19.360 € (-0,10 %)     MELEXIS 72.000 € (-0,69 %)     KINEPOLIS GROUP 40.900 € (+0,62 %)     AGEAS 72.650 € (-0,14 %)     SYENSQO 79.550 € (-1,55 %)     GBL 75.650 € (-0,13 %)     ACKERMANS V.HAAREN 264.800 € (+0,30 %)     ELIA GROUP 132.100 € (+0,76 %)     SHURGARD 24.150 € (+1,26 %)     FLUXYS BELGIUM D 20.100 € (0,00 %)     KBC 130.850 € (+0,93 %)     AZELIS GROUP 11.910 € (-0,08 %)     COLRUYT 38.440 € (+0,52 %)     ONTEX GROUP 2.470 € (-1,00 %)     BANQUP GROUP 2.200 € (-0,45 %)     LOTUS BAKERIES 12 700.000 € (+2,92 %)     BARCO 7.970 € (+0,25 %)     CIE BOIS SAUVAGE 300.000 € (-0,33 %)     SIPEF 97.000 € (+4,64 %)     XIOR 27.500 € (-0,18 %)     GIMV 43.950 € (0,00 %)     MONTEA 66.200 € (-0,75 %)     ONWARD MEDICAL 2.405 € (+0,63 %)     FAGRON 22.400 € (+0,90 %)     VASTNED 29.050 € (0,00 %)     BPOST 1.390 € (-0,57 %)     SOFINA 249.600 € (+0,32 %)     PROXIMUS 6.235 € (-0,48 %)     ACCENTIS 0.027 € (0,00 %)     UMICORE 23.660 € (-2,31 %)     KBC ANCORA 92.200 € (+0,77 %)     TUBIZE-FIN 185.200 € (-0,86 %)     EKOPAK 4.085 € (+1,36 %)     CARE PROPERTY INV. 12.180 € (+0,16 %)     EVS 28.050 € (+0,36 %)     TESSENDERLO 21.150 € (-0,70 %)     INCLUSIO SA/NV 17.400 € (0,00 %)     CELYAD ONCOLOGY 0.269 € (-0,37 %)     OPTION 3.910 € (-2,74 %)     ATENOR 1.270 € (0,00 %)     VGP 80.400 € (+0,25 %)     OXURION 0.003 € (0,00 %)     WERELDHAVE BELGIUM 53.000 € (+0,38 %)     CENERGY 23.260 € (+4,21 %)     IBA 15.960 € (+0,88 %)     ORANGE BELGIUM 22.100 € (+0,45 %)     TITAN S.A. 51.800 € (+1,57 %)     FLORIDIENNE 58.500 € (-0,85 %)  
   EMEIS 14.450 € (+2,63 %)     ATON 0.012 € (+3,51 %)     HAVAS 19.000 € (-0,52 %)     74SOFTWARE 38.000 € (0,00 %)     MEDIANTECHNOLOGIES 4.680 € (+1,19 %)     BNP PARIBAS ACT.A 113.200 € (+1,07 %)     GALP ENERGIA-NOM 20.510 € (-0,19 %)     SOCIETE GENERALE 83.860 € (+0,89 %)     2CRSI 28.400 € (+2,38 %)     AXA 44.880 € (+0,34 %)     STMICROELECTRONICS 47.700 € (-0,70 %)     HAFFNER ENERGY 0.649 € (-6,48 %)     TOTALENERGIES 75.170 € (-0,48 %)     EDENRED 28.010 € (+1,08 %)     OVH 16.420 € (+1,67 %)     SBM OFFSHORE 34.900 € (0,00 %)     VINCI 122.750 € (-0,45 %)     WORLDLINE 12.540 € (+6,13 %)     AIR LIQUIDE 169.240 € (-0,65 %)     ENERGISME 0.004 € (+4,76 %)     SLIGRO FOOD GROUP 10.660 € (-0,19 %)     AIR FRANCE -KLM 12.400 € (+0,53 %)     LVMH 467.300 € (+0,51 %)     PERNOD RICARD 68.560 € (+0,88 %)     ING GROEP N.V. 31.190 € (+0,94 %)     VALERIO TX 0.758 € (-0,52 %)     SOITEC 135.150 € (+2,62 %)     PHARMING GROUP 1.023 € (+1,89 %)     PROSUS 37.948 € (-1,84 %)     THEON INTERNAT 38.380 € (+1,32 %)     ARGAN 72.900 € (-0,14 %)     WOLTERS KLUWER 68.540 € (-0,90 %)     ADYEN 1 042.800 € (+14,59 %)     GROUPE LDLC 12.220 € (-0,97 %)     ATOS GROUP 29.980 € (+1,22 %)     AALBERTS NV 44.760 € (+0,40 %)     SCHNEIDER ELECTRIC 310.200 € (-0,26 %)     SAFRAN 364.300 € (+0,19 %)     CSG 18.834 € (+2,08 %)     STELLANTIS NV 4.726 € (+2,04 %)     REXEL 37.840 € (+0,61 %)     FASTNED 35.900 € (+9,45 %)     BIOPHYTIS 0.051 € (+36,53 %)     RIBER 10.120 € (+1,61 %)     BONDUELLE 8.690 € (-0,11 %)     GTT 203.000 € (+0,50 %)     VIVENDI SE 1.628 € (-0,18 %)     POSTNL 0.925 € (+0,54 %)     ASML HOLDING 1 580.800 € (+0,88 %)     VALBIOTIS 0.884 € (+7,54 %)     EURAZEO 51.800 € (+0,10 %)     AMUNDI 95.350 € (+0,32 %)     ADUX 1.230 € (+4,24 %)     SARTORIUS STED BIO 181.500 € (+0,67 %)     DANONE 67.400 € (+0,57 %)     ARAMIS GROUP 4.305 € (+1,18 %)     ENGIE 26.110 € (+0,54 %)     AEGON 8.220 € (+0,24 %)     SAINT GOBAIN 84.760 € (+0,62 %)     VALEO 14.640 € (+0,58 %)  
News Réglementées
05/01/2023 14:00

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

New York, 01/05/2023 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical


NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.

Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital investors throughout the day on January 12, 2023.

About Laxxon Medical Corporation

Laxxon Medical is a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for the development, manufacture, and commercialization of pharmaceutical dosage forms.

For more information, visit www.laxxonmedical.com or follow Laxxon Medical on LinkedIn or Twitter.

Investor Contact:

Alexander Ruckdaeschel
Chief Strategy Director
a.ruckdaeschel@laxxonmedical.com

Media Contact:

Frances Hoggard
Communications Manager
f.hoggard@laxxonmedical.com

SOURCE: Laxxon Medical Corporation



01/05/2023 EQS Newswire / EQS Group AG



fncls.ssp?fn=show_t_gif&application_id=1527693&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière